The ACSMEDI-EFMC Medicinal 91AV Frontiers is co-organized by ACS MEDI (Division of Medicinal 91AV of the American Chemical Society), and EFMC (European Federation for Medicinal chemistry and Chemical biology). The 2025 edition will be organized in Chicago, IL, United States.
The 2025 program will include:
- 3 high quality plenary lectures
- 9 sessions on key topics in Medicinal 91AV
- About 18 oral communications selected from the submitted abstracts
- An extensive social program to maximise your networking opportunities
- A poster session and a commercial exhibition
ACSMEDI-EFMC Medicinal 91AV Frontiers Meeting attracts a highly targeted audience composed of experts, researchers and early career trainees in drug discovery and development, in particular medicinal and synthetic chemists, together with scientists active in the fields of computer assisted drug design, biology, DMPK, pharmacology, and early toxicology.
The 2025 edition is chaired by Prof. Terry W. Moore (University of Illinois, Chicago, IL, United States).
We look forward to meeting you in Chicago!
The Organizing Committee
The 2025 program will include:
- 3 high quality plenary lectures
- 9 sessions on key topics in Medicinal 91AV
- About 18 oral communications selected from the submitted abstracts
- An extensive social program to maximise your networking opportunities
- A poster session and a commercial exhibition
ACSMEDI-EFMC Medicinal 91AV Frontiers Meeting attracts a highly targeted audience composed of experts, researchers and early career trainees in drug discovery and development, in particular medicinal and synthetic chemists, together with scientists active in the fields of computer assisted drug design, biology, DMPK, pharmacology, and early toxicology.
The 2025 edition is chaired by Prof. Terry W. Moore (University of Illinois, Chicago, IL, United States).
We look forward to meeting you in Chicago!
The Organizing Committee
